Melanoma News

Moderna's mRNA melanoma vaccine, intismeran, has shown promise in early trials by slowing the recurrence of skin cancer in patients. This development suggests t

A personalized cancer vaccine developed by Moderna and Merck has shown success in a final-stage melanoma trial. Researchers are hopeful this approach could be u

Merck and Moderna announced that their cancer vaccine for melanoma successfully met its primary and key secondary endpoints in a Phase 3 trial, showing improved

Moderna's new mRNA cancer vaccine is designed to combat melanoma, the most aggressive form of skin cancer, which causes approximately 2,600 deaths annually in t

Moderna's personalized mRNA cancer vaccine achieved key goals in a Phase 3 melanoma trial, leading to a significant stock rally. This breakthrough offers new ho

Scientists have developed a skin cancer vaccine that significantly reduces the risk of dying from the disease, offering hope for its application to other cancer

A personalized cancer vaccine developed by Merck and Moderna shows promise for melanoma patients, significantly reducing cancer recurrence when combined with Ke

An experimental, personalized melanoma vaccine, optimized with artificial intelligence, shows promising results in reducing the risk of cancer recurrence or spr

Moderna and Merck announced that a new personalized mRNA vaccine significantly reduced the risk of melanoma recurrence and spread in a late-stage trial, marking

Merck and Moderna announced that their personalized mRNA vaccine successfully prevented melanoma recurrence in high-risk patients during a late-stage trial, tho

Moderna and Merck's personalized mRNA cancer vaccine has met its primary goals in a Phase 3 trial for high-risk melanoma, marking a significant breakthrough and

Moderna and Merck have announced that their experimental mRNA vaccine has shown success in preventing the return and spread of melanoma in high-risk patients. T

Moderna's stock surged by 120% following positive Phase 3 trial results for its mRNA cancer vaccine when combined with Merck's Keytruda, offering new hope for m

Moderna shares surged 135% after its personalized mRNA cancer vaccine, combined with Keytruda, showed positive results in a late-stage trial for melanoma, signi

Moderna and Merck have reported promising results from a late-stage trial combining Moderna's mRNA therapy, intismeran, with Merck's Keytruda for melanoma patie

An experimental mRNA drug has shown a breakthrough in treating deadly skin cancer, with over 8,500 Americans projected to die from melanoma this year.

Whole-genome sequencing of brown bullhead catfish tumors has revealed a novel type of naturally occurring transmissible cancer, specifically melanoma. This find

A genetic study indicates that a rare contagious melanoma skin cancer is spreading among catfish in lakes across Quebec and the northeastern U.S.

A mother initially mistook a red mark for an insect bite but was diagnosed with deadly melanoma after groundbreaking NHS AI technology identified it as cancer,